CompoAtlas

Sapino pastilles

Natural health product licensed in Canada

Licence holder
DMG Services Inc
NPN or DIN-HM
80021340
Status
Active licence
Licence date
31 August 2010
Revision date
22 November 2024
Form
Pastille
Route of administration
Orale
Application type
TPD Cat IV/LS

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
(1R, 2S, 5R)-5-méthyl-2-(1-méthyléthyl)cyclohexanol

Source : Mentha X piperita - feuille

9 mgNot calculated
Eucalyptus spp.

Source : Eucalyptus - feuille

2.25 mgNot calculated

Non-medicinal ingredients

Stéarate de magnésium, d-Sorbitol, Complexes de cuivre de chlorophylles et de chorophyllines, Essence d'aiguilles de Sapin Canadien

PopulationAgeQuantity per servingFrequency
Enfantsminimum: 12 years1 Pastilleminimum: 1 Tous les jours ; maximum: 10 Tous les jours
AdultesNot specified1 Pastilleminimum: 1 Tous les jours ; maximum: 10 Tous les jours

Uses authorised in Canada

Aide à soulager/atténuer la congestion nasale, dégage les voies nasales. Pour le soulagement temporaire du mal de gorge. Pour le soulagement temporaire de la toux.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80021340

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line